- Research Interests:
Risk stratification of patients with metastatic kidney cancer undergoing cytoreductive nephrectomy; Identification of novel biomarkers to assess indolent vs. aggressive prostate cancer; Use of novel PSMA PET/CT tracers in prostate cancer; Development of treatment paradigms for small renal masses
- Clinical Practice:
- Benign Prostatic Hyperplasia (BPH), Bladder Cancer, Kidney Cancer Treatment, Prostate Cancer Treatment, Testicular Cancer, VHL Care, Cystectomy, Nephrectomy, Prostatectomy, TURP, Brachytherapy, Penile Cancer, Urology, Prostate Services
- Associate Professor
Stephen H. Culp, MD, is a urologist who specializes in caring for patients with urologic cancers, including kidney, bladder and prostate cancer. An active researcher, Culp has a particular interest in the study of kidney cancer.
Culp grew up in South Carolina, the son of a nurse and a Methodist minister. When he was an undergrad at Emory University in Atlanta, his father was diagnosed and later succumbed to metastatic kidney cancer. It was this tragic loss that inspired Culp to make cancer research and treatment his life’s work.
He attended medical school at Virginia Commonwealth University in Richmond, and completed his surgical and urologic residency training at the University of Washington in Seattle, Washington. Culp then pursued a fellowship at University of Texas MD Anderson Cancer Center in Houston, Texas.
- Virginia Commonwealth University Medical College of Virginia 2002
- University of Washington (Surgery and Urology)
- University of Texas MD Anderson Cancer Center 2011